The benefits of purified cytoplasm of pollen in reducing menopausal symptoms in peri- and post-menopause: an Italian multicenter prospective observational study.


Journal

Minerva obstetrics and gynecology
ISSN: 2724-6450
Titre abrégé: Minerva Obstet Gynecol
Pays: Italy
ID NLM: 101777346

Informations de publication

Date de publication:
12 2022
Historique:
pubmed: 27 11 2021
medline: 20 12 2022
entrez: 26 11 2021
Statut: ppublish

Résumé

Purified cytoplasm of pollen (PCP) is a non-hormonal herbal remedy used to manage vasomotor symptoms (VMS), sleep and mood disorders in menopausal women not relying on Hormone Replacement Therapy (HRT). Many studies demonstrated its efficacy and safety in post-menopause but few data are available about peri-menopause. This is a multicenter prospective observational study on Italian symptomatic women in peri- and post-menopause referring to gynecology clinics of different areas of Italy, evaluating the effects of PCP therapy on hot flashes (HFs) and other parameters included in the Greene Climacteric Scale (GCS). We recruited 108 peri- and post-menopausal women (mean age 53.8±4 years), evaluating them at baseline (V0) and after 3 months of PCP treatment (V1). Basal median value of all items of GCS did not differ among all subjects. We found a significant improvement of HFs (P<0.0001) and night sweats (P<0.0001) between V0 and V1. Additionally, all items of GCS apart from loss of sensitivity to limbs (P=0.0746) significantly ameliorated after PCP therapy (P<0.05). According to these findings, PCP may be considered as an efficacious alternative non-hormonal treatment for the management of VMS as well as mood and sleep disturbances in both peri- and post-menopause.

Sections du résumé

BACKGROUND
Purified cytoplasm of pollen (PCP) is a non-hormonal herbal remedy used to manage vasomotor symptoms (VMS), sleep and mood disorders in menopausal women not relying on Hormone Replacement Therapy (HRT). Many studies demonstrated its efficacy and safety in post-menopause but few data are available about peri-menopause.
METHODS
This is a multicenter prospective observational study on Italian symptomatic women in peri- and post-menopause referring to gynecology clinics of different areas of Italy, evaluating the effects of PCP therapy on hot flashes (HFs) and other parameters included in the Greene Climacteric Scale (GCS).
RESULTS
We recruited 108 peri- and post-menopausal women (mean age 53.8±4 years), evaluating them at baseline (V0) and after 3 months of PCP treatment (V1). Basal median value of all items of GCS did not differ among all subjects. We found a significant improvement of HFs (P<0.0001) and night sweats (P<0.0001) between V0 and V1. Additionally, all items of GCS apart from loss of sensitivity to limbs (P=0.0746) significantly ameliorated after PCP therapy (P<0.05).
CONCLUSIONS
According to these findings, PCP may be considered as an efficacious alternative non-hormonal treatment for the management of VMS as well as mood and sleep disturbances in both peri- and post-menopause.

Identifiants

pubmed: 34825790
pii: S2724-606X.21.04964-2
doi: 10.23736/S2724-606X.21.04964-2
doi:

Types de publication

Observational Study Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

516-521

Investigateurs

Angelo Cagnacci (A)
Annibale Volpe (A)
Vincenzo DE Leo (V)
Costantino DI Carlo (C)
Giuseppe Bifulco (G)
Marco Gambacciani (M)
Stefania Alfieri (S)
Nicoletta Biglia (N)
Gloria Bonaccorsi (G)
Salvatore Caruso (S)
Ettore Cicinelli (E)
Pasquale DE Franciscis (P)
Alessandro Gambera (A)
Anna Grasso (A)
Filippo Murina (F)
Anna M Paoletti (AM)
Franco Vicariotto (F)
Paola Villa (P)
Simona Ambroggio (S)
Antonio Azzena (A)
Angelamaria Becorpi (A)
Anna Capozzi (A)
Demetrio Costantino (D)
Lino Del Pup (L)
Amelia Forte (A)
Mario Gallo (M)
Giuseppina Grassi (G)
Stefano Lello (S)
Silvia Maffei (S)
Carlo Mapelli (C)
Franca Nocera (F)
Maria C Pandolfo (MC)
Roberta Rossi (R)
Massimo Stomati (M)
Giovanni Grandi (G)
Livio Leo (L)
Giampaolo Mainini (G)
Anna Parrini (A)
Anna Pasi (A)
Giovanni Scambia (G)
Veronica Quagliarini (V)
Luca Zurzolo (L)

Auteurs

Stefano Lello (S)

Istituto Dermopatico dell'Immacolata - IRCCS, Rome, Italy.
Department of Maternal and Child Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.

Anna Capozzi (A)

Istituto Dermopatico dell'Immacolata - IRCCS, Rome, Italy - lello.stefano@gmail.com.
Department of Maternal and Child Health, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.

Anjeza Xholli (A)

Clinic of Obstetrics and Gynecology, IRCCS San Martino University Hospital, Genoa, Italy.

Angelo Cagnacci (A)

Clinic of Obstetrics and Gynecology, IRCCS San Martino University Hospital, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH